BroadPharm

Founded in 2014, BroadPharm has established itself as a key supplier of specialized research reagents, particularly PEG derivatives and click chemistry tools, to the global life sciences industry. The company operates a robust catalog business with over 8,000 PEG linkers and thousands of other reagents in stock, emphasizing high purity, overnight shipping, and custom synthesis services. Its technology, including the proprietary MagicLink™ crosslinking platform, supports critical R&D areas such as antibody-drug conjugate (ADC) development, PROTACs, oligonucleotide synthesis, and lipid nanoparticle (LNP) formulation for drug delivery. BroadPharm's model is built on enabling and accelerating the research of its clients rather than developing its own therapeutic pipeline.

Specialized chemical synthesis platform for PEG linkers, click chemistry reagents, ADC linkers, drug delivery lipids, and bioconjugation tools, including the proprietary MagicLink™ protein crosslinking technology.

Operates in a competitive market with major players like Thermo Fisher Scientific and Merck KGaA (Sigma-Aldrich), and specialized pure-play competitors such as Creative PEGWorks, JenKem Technology, and Avanti Polar Lipids. Differentiation is achieved through catalog breadth, product purity, fast shipping, custom synthesis capabilities, and proprietary technologies like MagicLink™.